tiprankstipranks
pc:avenc

AvenCell Therapeutics Inc

51 Moulton St Cambridge, Massachusetts 02138, US
https://www.avencell.com/
AvenCell Therapeutics Inc is a clinical-stage cell therapy company specializing in the development of both autologous and allogeneic switchable CAR-T cell therapies. The company is focused on utilizing its proprietary Universal Switchable CAR-T cell therapy platform to treat a wide range of hematologic malignancies and autoimmune diseases.

Leadership & Board

Current Number of Employees64
Current LinkedIn Followers4,184

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$112M
Total Amount Raised$112M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$112M
Latest Funding Amount$112M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

AvenCell Therapeutics Inc had 64 employees as of May 18, 2026. The number of employees increased by 0 (0.00%) week-over-week.
64Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

AvenCell Therapeutics Inc had 4,184 followers as of May 18, 2026. The number of followers increased by 12 (0.29%) week-over-week.
4,184Latest Followers Count
12(0.29%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series B
$112.00M

Investors

Related News and Analysis